Vicarious Surgical (NYSE:RBOT) stock was down in after-hours trading after it reported losses that were wider than Wall Street expectations. The Waltham, Massachusetts–based robotic surgery technology developer this evening reported an adjusted net loss of $18.2 million, or 15¢ per share, for the quarter ended March 31, 2022. The loss was more than triple the […]
Vicarious Surgical
Vicarious Surgical names VP of operations
Vicarious Surgical this week announced that it appointed John Mazzola as VP of operations. Mazzola brings more than 30 years of global operations and engineering management experience to the Waltham, Massachusetts-based surgical robotics company. He will be responsible for leading the strategic manufacturing plans for the Vicarious system as development progresses. “We are excited to […]
Our top medtech stories of 2021
Covering the medical device industry enables writers to report on a wide range of world-changing news – financial markets, the pandemic, and the global supply chain problems – while also centering on jaw-dropping technology that improve patient care. You’ll hear all those issues covered in our editorial’s team summation of their Top Stories of 2021 […]
The top 5 medtech news stories of 2021
The past year saw significant changes in the medtech space. Our editorial team picked their top stories. The lingering COVID-19 pandemic was top of mind in 2021, but there was much more going on in the medical device industry. The Life Sciences editorial team here at WTWH Media discussed their top picks during the December […]
Vicarious Surgical details its regulatory plans with FDA
Vicarious Surgical (NYSE:RBOT) announced in its quarterly earnings report that it set its FDA regulatory process in motion with a pre-submission. CEO Adam Sachs said in a news release that the robotic surgery technology developer, which just completed its first quarter as a publicly-traded company, filed a “detailed regulatory plan” in the form of a […]
Vicarious Surgical stock continues to rise
It’s so far, so good for Vicarious Surgical (NYSE:RBOT) during its first week of trading as a public company. The robotic surgery company’s shares were up more than 19% to $15.05 by midday today. During the company’s first day of trading yesterday, shares rose 2% to $12.60 apiece, even as the Dow Jones Industrial Average […]
DTW Weekly Podcast – Digging Deeper into Cleerly Health’s $43 million round
In this week’s DeviceTalks Weekly Podcast, we talk with Dr. James Min, the founder and CEO of Cleerly Health, a potentially disruptive diagnostics company that raised $43 million last week. Min explains how Cleerly Health formed from his work at Weill Cornell Medicine. But, more importantly, for entrepreneurs and executives, he walks listeners through the […]
MedTech 100 roundup: Nearing new highs once again
Having hit a downturn as the summer neared, the medtech industry is now consistently on the rise as June comes to a close. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 25) at 113.42 points, producing a 2.5% rise from the 110.64-point mark set […]
Vicarious Surgical opens new corporate HQ in Massachusetts
Vicarious Surgical announced today that it established a new corporate headquarters in Waltham, Mass. The company, which seeks to bring robotics and virtual reality to minimally invasive surgery, said in a news release that the new headquarters will expand its core business functions and house approximately 250 employees. With what the company describes as a […]
MedTech 100 roundup: Industry skies to all-time high
The medtech industry hit a slight lull in the early stages of 2021 and, after signs of a rebound, it has soared beyond levels ever before seen. MassDevice‘s MedTech 100 Index had been building up steam in the month of April, rising from 102.16 points at the beginning of March all the way to 109.39 to […]
DTW Podcast: How is Zimmer Biomet waging the ortho data war? Do medical devices carry physics-based biases?
In this week’s DeviceTalks Weekly Podcast, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics. Teplitsky, an engineer who built her medtech career in cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of […]
